GMP – Page 16 – Pharma.Tips

Deviation history questioned during inspection preparation – documentation gaps reviewers flag

How to Address Documentation Gaps for Deviation History in Preparation for Inspections In the fast-evolving landscape of pharmaceutical manufacturing and quality, the challenge of managing deviation history effectively is a…

CAPA effectiveness doubted during inspection preparation – preventing PQ suspension

“`html Enhancing CAPA Effectiveness in Preparation for WHO Prequalification Inspections The challenge of ensuring effective Corrective and Preventive Actions (CAPA) becomes significantly critical in the context of WHO Prequalification (PQ)…

Over-drying risk during granulation drying – process efficiency optimization strategy

Strategies to Mitigate Over-Drying Risks in Granulation Drying Processes The pharmaceutical industry is continually challenged by the intricacies of granulation drying processes, particularly concerning the risk of over-drying. This phenomenon…

API change not reported during variation management – CAPA expectations for PQ approval

Managing Unreported API Changes in Variation Management for PQ Compliance In today’s pharmaceutical environment, managing the integrity of Active Pharmaceutical Ingredients (APIs) is critical for compliance with quality standards. A…

API change not reported during dossier submission – how to defend manufacturing readiness

Mitigating Risks of Unreported API Changes During Dossier Submission In the pharmaceutical landscape, the integrity of the Active Pharmaceutical Ingredient (API) dossier is paramount. However, discrepancies such as API change…

API change not reported during inspection preparation – CAPA expectations for PQ approval

CAPA Expectations for Reporting API Changes During Inspection Preparation In the pharmaceutical manufacturing landscape, the accuracy of documentation and communication regarding Active Pharmaceutical Ingredient (API) changes is crucial, especially during…

Air entrapment during mixing during CPV review – robust preparation optimization strategy

“`html Addressing Air Entrapment During Mixing: An Optimized Approach for Continuous Process Verification Review During Continuous Process Verification (CPV) review, the phenomenon of air entrapment during mixing can manifest as…

CAPA effectiveness doubted during requalification – documentation gaps reviewers flag

Enhancing CAPA Effectiveness During Requalification to Address Documentation Gaps The challenge of ensuring CAPA effectiveness during requalification is a persistent issue that can lead to significant regulatory scrutiny. With the…

Stability data gaps during inspection preparation – documentation gaps reviewers flag

Addressing Stability Data Gaps During Inspection: An Actionable Playbook In the world of pharmaceutical manufacturing and quality systems, maintaining robust stability data during inspection preparation is vital. Regulatory agencies such…

Deviation history questioned during requalification – documentation gaps reviewers flag

Addressing Deviation Histories During Requalification: A Playbook for Compliance and Quality Assurance Deviation histories play a critical role in ensuring compliance with Good Manufacturing Practices (GMP) and maintaining rigorous quality…

Sampling bias during CPV review – process capability enhancement

Addressing Sampling Bias in Continuous Process Verification for Enhanced Process Capability In pharmaceutical manufacturing, maintaining a high level of product quality is of utmost importance. One common complication that can…

Stability data gaps during requalification – how to defend manufacturing readiness

Addressing Gaps in Stability Data During Requalification for Manufacturing Readiness In the highly regulated pharmaceutical industry, maintaining manufacturing readiness is essential for compliance with GMP standards. One critical area often…